Physician profile
Mohammad M Rahman
NPI 1295859023
$629.24
in general payments reported to CMS, 2019-2025
10 companies · $41.99 in 2025
The $41.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.55 · 2022: $125 · 2023: $125 · 2024: $279 · 2025: $41.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.91 | 2022-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $125.00 | 2023 | Arexvy |
| Exact Sciences Corporation | $100.15 | 2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $55.17 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $53.37 | 2024 | |
| Abbvie INC. | $42.21 | 2024-2025 | |
| Lilly USA, LLC | $39.31 | 2021 | |
| Averitas Pharma INC. | $29.81 | 2024 | Qutenza |
| Redhill Biopharma INC. | $19.24 | 2021 | |
| Abbott Laboratories | $19.07 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.